Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TCDA

Tricida (TCDA) Stock Price, News & Analysis

Tricida logo

About Tricida Stock (NASDAQ:TCDA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.11
$0.19
52-Week Range
N/A
Volume
31.13 million shs
Average Volume
17.62 million shs
Market Capitalization
$6.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.

Receive TCDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tricida and its competitors with MarketBeat's FREE daily newsletter.

TCDA Stock News Headlines

Patrick G Enright's Net Worth
Trump Quietly Planning $15 Trillion Crypto Shocker
Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.
Tricida Inc (TCDAQ)
Firm Retention Summary: Tricida Inc.
Tricida Announces Third Quarter 2022 Financial Results
Tricida Provides Strategic Update
See More Headlines

TCDA Stock Analysis - Frequently Asked Questions

Tricida, Inc. (NASDAQ:TCDA) posted its quarterly earnings results on Monday, November, 8th. The company reported ($0.79) EPS for the quarter, missing analysts' consensus estimates of ($0.70) by $0.09.

Tricida (TCDA) raised $175 million in an initial public offering on Thursday, June 28th 2018. The company issued 10,300,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, J.P. Morgan and Cowen served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tricida investors own include Sorrento Therapeutics (SRNE), Alibaba Group (BABA), NIO (NIO), Pfizer (PFE), Energy Transfer (ET), Teladoc Health (TDOC) and Sesen Bio (SESN).

Company Calendar

Last Earnings
11/08/2021
Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TCDA
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$176.57 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
35,851,000
Market Cap
$6.01 million
Optionable
Not Optionable
Beta
0.22
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:TCDA) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners